aPC Central Resource
Library

Resources for you and your patients to help navigate advanced prostate cancer

For healthcare providers

IncreMENtal Nurse Brochure

The IncreMENtal Nurse Brochure helps nurses prepare their patients for the IncreMENtal program by providing information covered in the program along with sample lessons, how to get patients to adhere to habit building, and more.

Prostate Cancer 360 Healthcare Provider Comprehensive Care Roadmap

Download a detailed guide that can help physicians prepare to manage ADT through each step of treatment.

ADT Initiation Letter

Download a letter to share with patients’ current providers detailing their ADT plan.

Classifying aPC

Download a printable quick-reference guide about classifying advanced prostate cancer to use in-office.

Diagnosing, Grading, and Staging aPC

Download a printable quick-reference guide about diagnosing, grading, and staging advanced prostate cancer to use in-office.

Mitigation Strategies

Download a printable quick-reference guide about side effect mitigation strategies for advanced prostate cancer to use in-office.

Find more information, including helpful downloads, for ELIGARD^® and RUBRACA^® at ELIGARDhcp.com and RubracaProstateHCP.com

RUBRACA is indicated for patients previously treated with any androgen receptor-directed therapy and a taxane-based chemotherapy.¹

Myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) occur in patients treated with RUBRACA, and are potentially fatal adverse reactions.

For Important Safety Information and full Prescribing Information for RUBRACA, visit RubracaProstateHCP.com.

ELIGARD for injectable suspension is a gonadotropin-releasing hormone (GnRH) agonist indicated for the treatment of advanced prostate cancer.²

ELIGARD may impair fertility in males of reproductive potential.

For Important Safety Information and full Prescribing Information for ELIGARD, visit ELIGARDhcp.com.

For patients

Side Effects Tracker

Download a worksheet your patients can use to keep track of side effects they experience while on treatment.

Prostate Cancer 360 Patient Comprehensive Care Roadmap

Download a helpful guide that can help prepare patients for ADT and walk them through what to expect during treatment.

IncreMENtal

IncreMENtal is a habit-building program for patients on ADT that includes comprehensive courses to be completed at their own pace. Patients can build a healthier lifestyle over time by learning about the importance of maintaining exercise, nutrition, and mental health to help them overcome ADT challenges.  

Your patients can visit ELIGARD and RUBRACA patient websites for more information about treatment at ELIGARD.com and RubracaProstate.com

RUBRACA is indicated for patients previously treated with any androgen receptor-directed therapy and a taxane-based chemotherapy.¹

Myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) occur in patients treated with RUBRACA, and are potentially fatal adverse reactions.

For Important Safety Information and full Prescribing Information for RUBRACA, visit RubracaProstateHCP.com.

ELIGARD for injectable suspension is a gonadotropin-releasing hormone (GnRH) agonist indicated for the treatment of advanced prostate cancer.²

ELIGARD may impair fertility in males of reproductive potential.

For Important Safety Information and full Prescribing Information for ELIGARD, visit ELIGARDhcp.com.

aPC Central Resource Library

Resources for you and your patients to help navigate advanced prostate cancer

For healthcare providers

IncreMENtal Nurse Brochure

IncreMENtal Nurse Brochure

Prostate Cancer 360 Healthcare Provider Comprehensive Care Roadmap

Prostate Cancer 360 Healthcare Provider Comprehensive Care Roadmap

ADT Initiation Letter

ADT Initiation Letter

Classifying aPC

Classifying aPC

Diagnosing, Grading, and Staging aPC

Diagnosing, Grading, and Staging aPC

Mitigation Strategies

Mitigation Strategies

Find more information, including helpful downloads, for ELIGARD® and RUBRACA® at ELIGARDhcp.com and RubracaProstateHCP.com

For patients

Side Effects Tracker

Side Effects Tracker

Prostate Cancer 360 Patient Comprehensive Care Roadmap

Prostate Cancer 360 Patient Comprehensive Care Roadmap

IncreMENtal

IncreMENtal

Your patients can visit ELIGARD and RUBRACA patient websites for more information about treatment at ELIGARD.com and RubracaProstate.com

Find more support for advanced prostate cancer

You are now leaving aPCcentral.com

Are you sure you want to leave?

aPC Central Resource
Library

Find more information, including helpful downloads, for ELIGARD^® and RUBRACA^® at ELIGARDhcp.com and RubracaProstateHCP.com

Are you sure you
want to leave?